Literature DB >> 23812205

Necrotizing pneumonia due to femoral osteomyelitis caused by community-acquired methicillin-resistant Staphylococcus aureus.

Naoki Iwanaga1, Yuichi Fukuda, Shigeki Nakamura, Yoshifumi Imamura, Taiga Miyazaki, Koichi Izumikawa, Hiroshi Kakeya, Katsunori Yanagihara, Hiroshi Soda, Takayoshi Tashiro, Shigeru Kohno.   

Abstract

A chest X-ray of a young healthy African-American man with acute respiratory failure revealed bilateral multiple nodular shadows in the lungs, while community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) was detected in blood and sputum cultures. Magnetic resonance imaging showed osteomyelitis of the left thigh, and computed tomography revealed bilateral cavitary lesions in the chest, indicating necrotizing pneumonia with pulmonary embolism caused by osteomyelitis as a result of infection with CA-MRSA. CA-MRSA should be suspected as a causative agent of severe community-acquired pneumonia, even in Japan, among patients who belong to communities at high risk of CA-MRSA infection.

Entities:  

Mesh:

Year:  2013        PMID: 23812205     DOI: 10.2169/internalmedicine.52.9561

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  2 in total

1.  Co-occurrence of antibiotic resistance and virulence Genes in Methicillin Resistant Staphylococcus aureus (MRSA) Isolates from Pakistan.

Authors:  Ufaq Tasneem; Mahnoor Majid; Khalid Mehmood; Fazal Ur Rehman; Saadia Andleeb; Muhsin Jamal
Journal:  Afr Health Sci       Date:  2022-03       Impact factor: 1.108

2.  Rapidly Progressive Multiple Cavity Formation in Necrotizing Pneumonia Caused by Community-acquired Methicillin-resistant Staphylococcus aureus Positive for the Panton-Valentine Leucocidin Gene.

Authors:  Yuki Takigawa; Keiichi Fujiwara; Takashi Saito; Takamasa Nakasuka; Taichi Ozeki; Sachi Okawa; Kenji Takada; Yoshitaka Iwamoto; Hiroe Kayatani; Daisuke Minami; Ken Sato; Miki Nagao; Takuo Shibayama
Journal:  Intern Med       Date:  2018-10-17       Impact factor: 1.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.